| 1888 PressRelease Home | Sign In | Sign Up | Contact Us | About Us | Sitemap |
|
|
|
||||||||||||
|
 |
 |
|
|
||||||||||||||||||
Gtcbio Press Release - Gtcbio.com |
|
02 JUL |
Peter Mayne, OSI Pharmaceuticals Presenting At GTCbio’s Global Clinical Trial Operations Conference |
| Peter Mayne from OSI Pharmaceuticals presenting on being an EU Qualified Person (QP) as a small offshoot of a virtual company at GTCbio’s Global Clinical Trial Operations conference. |
|
01 JUL |
Larry A Blankstein From Genzyme Will Present At GTCbio’s Global Clinical Trial Operations Conference |
| Larry A. Blankstein from Genzyme giving a presentation entitled “An Interactive Lessons Learned Process to Optimize Sponsor and Provider Performance on Global Trials” at GTCbio’s Global Clinical Trial Operations Conference. |
|
01 JUL |
Mark Lanfear From Roche To Speak At GTCbio’s Global Clinical Trial Operations Conference |
| Mark Lanfear, Regional Manager of Kforce-Roche Strategic Alliance at Roche to present on outsourcing clinical trials in emerging regions at GTCbio’s Global Clinical Trial Operations Conference. |
|
01 JUL |
Michele Pontinen From Capgemini LLC To Speak At GTCbio’s Global Clinical Trial Operations Conference |
| Michele Pontinen from Capgemini to present “Forget About the Boulders – I’m Interested in Mining for the Diamonds!” Data Mining Made Possible by Clinical IT - a Real Life Industrialized Model at GTCbio’s Global Clinical Trial Operations Conference. |
|
29 JUN |
Brahm Goldstein Of Novo Nordisk To Speak At GTCbio’s Global Clinical Trial Operations Conference |
| Brahm Goldstein Novo Nordisk speaking regarding a rational approach towards pediatric drug development in the pharmaceutical industry at GTCbio’s Global Clinical Trial Operations Conference on 9/25-26 |
|
28 JUN |
Didier Basseras From Sanofi Aventis To Speak GTCbio’s Global Clinical Trial Operations Conference |
| Didier Basseras from Sanofi Aventis giving a presentation entitled “Clinical Packaging and Labelling: Is There Room to Innovate?” at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. |
|
27 JUN |
Cosimo Spera From Decision View Co. Speaking At GTCbio’s Global Clinical Trial Operations Conference |
| Cosimo Spera from Decision View Co. will give a presentation entitled “Marrying Complex Mathematical Models with Highly Usable Software Solutions to Improve Trial Enrollment Performance” at GTCbio’s Global Clinical Trial Operations Conference |
|
27 JUN |
Franco Pasquale From Genentech Presenting At GTCbio’s Global Clinical Trial Operations Conference |
| Franco Pasquale, Sr Manager of Manufacturing Collaborations at Genentech to present on devising an international clinical trial distribution strategy using Genentech’s approach at GTCbio’s Global Clinical Trial Operations Conference |
|
27 JUN |
Gavin Choy From Supergen Presenting At GTCbio’s Global Clinical Trial Operations Conference |
| Gavin Choy, VP of Clinical Research Operations at SuperGen, Inc. giving a presentation entitled ADME in Phase 1 Clinical Trials at GTCbio’s Global Clinical Trial Operations Conference on September 25-26, 2008 in San Diego. |
|
26 JUN |
Helen Niu From Amgen Presenting At GTCbio’s Global Clinical Trial Operations Conference |
| Dr. Helen Niu, Director of Global Development Operations at Amgen presenting on development strategies for bio-pharmaceuticals in emerging Asian countries at GTCbio’s Global Clinical Trial Operations Conference on Sept 25-26 in San Diego. |
|
26 JUN |
Kathleen Drennan From Iris Trials To Present At GTCbio’s Global Clinical Trial Operations Conference |
| Kathleen Drennan from Iris Global Clinical Trial Solutions giving a presentation entitled “Clinical Trials In Kids; A Special Population Requiring A Unique Approach” at GTCbio’s Global Clinical Trial Operations Conference on Sept 25-26 in San Diego. |
|
17 JUN |
Amrit Ray, VP At BMS To Present At Global Clinical Trial Operations Conf. On Sept 25-26 In San Diego |
| Amrit Ray, Vice President of Bristol-Myers Squibb will give the keynote presentation at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. Dr. Ray will give a presentation entitled “The Next Generation of Pharmacovigilance - Clinical Trials and Drug Development in the New Era of Drug Safety.” |
|
15 JUN |
VP Of Drug Discovery At Phylogica To Present At GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference |
| Paul Watt, Vice President of Drug Discovery at Phylogica to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. |
|
14 JUN |
Lino Gonzalez Of Genentech To Present At GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference |
| Lino Gonzalez from Genentech to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA |
|
14 JUN |
Group Leader Of Experimental Therapeutics At Celgene To Present At GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference |
| Kanji Takada, Group Leader of Experimental Therapeutics at Celgene to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. |
|
13 JUN |
Ludmilla Morazova-Roche At Umea University In Sweden To Present At GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference |
| Ludmilla Morazova-Roche at Umeå University in Sweden to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development conference on September 8-9, 2008 in San Diego, CA. |
|
13 JUN |
CTO & VP Of Research At Baxter Healthcare To Present At Gtcbio’s 2nd Protein Therapeutics Discovery & Development Conference |
| Larry Brown, Chief Technology Officer & VP of Research at Baxter Healthcare to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. |
|
12 JUN |
Director Of Research At BN ImmunoTherapeutics Will Present At GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference |
| Alain Delcayre, Director of Research at BN ImmunoTherapeutics will Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development conference on September 8-9, 2008 in San Diego, CA |
|
12 JUN |
Ingrid Cruzado-Park From Beckman Coulter, Inc To Present At GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference |
| Ingrid Cruzado-Park from Beckman Coulter, Inc to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development conference on September 8-9, 2008 in San Diego, CA. |
|
11 JUN |
Site Head Of Pfizer La Jolla To Give Plenary Keynote Address At 4th Modern Drug Discovery & Development Summit |
| SVP and Site Head of Pfizer La Jolla to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 – San Diego, CA). |
|
22 APR |
Chip Allee To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference |
| Dr. Allee will speak on the issue of special data management considerations for kinetics assays. |
|
22 APR |
Can Ozbal To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference |
| Dr. Ozbal will be speaking on label-free HTS of intractable targets with rapid-fire mass spectrometry. |
|
21 APR |
Gary Piazzo, Program Director Of The Southern Research Molecular Libraries Screening Center To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference |
| Dr. Gary Piazzo, Program Director of the Southern Research Molecular Libraries Screening Center at Southern Research Institute will be giving a presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Piazzo will be speak on “HTS to Identify MRP1 Inhibitors for Reversal of Multidrug Resistance.” |
|
21 APR |
Associate Director At Medimmune To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11 |
| Robert Lechleider, Associate Director at MedImmune to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA |
|
20 APR |
Gloria Meng, Senior Scientist Of Technology At Genentech To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference On June 5-6, 2008 In San Francisco, CA |
| MONROVIA, CA – Dr. Y. Gloria Meng, Senior Scientist of Technology at Genentech will give a presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Meng will speak on electrochemiluminescence to detect surface proteins on live cells. |
|
20 APR |
Senior Research Scientist, Intrinsic Bioprobes To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11, 2008 In Boston, MA |
| Urban Kiernan, Senior Research Scientist, Intrinsic Bioprobes to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA |
|
20 APR |
Tim Harris Of Saic-frederick To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11, 2008 In Boston, MA |
| Tim Harris, Director of Advanced Technology Program and Corporate VP of Technology at SAIC-Frederick to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA |
|
20 APR |
Senior Director Of Technology Management At Roche To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11 |
| Thomas Li, Senior Director of Technology Management at Roche to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA |
|
19 APR |
Walter Carney To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11, 2008 In Boston, MA |
| Walter Carney, Head of Oncogene Sciences at Siemens to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA |
|
19 APR |
Victor Levenson Of Northwestern University To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11, 2008 In Boston, MA |
| Victor Levenson, Director and Research Associate Professor, Robert H. Lurie Comprehensive Cancer Center at Northwestern University to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA |
|
19 APR |
Saju Nettikadan To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11 |
| Saju Nettikadan, Director of Emerging Technologies at BioForce Nanosciences to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA. |
|
17 APR |
Matthew Olson To Speak At GTCbio’s 3rd Assay Development & Screening Technologies Conference On June 5-6 |
| Matthew Olson Principle Research Scientist at Johnson & Johnson to Speak at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA |
|
17 APR |
Yudong He, Scientific Director, Rosetta Inpharmatics To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11, 2008 In Boston, Ma |
| Dr. Yudong He, Scientific Director, Rosetta Inpharmatics will be presenting at GTCbio’s 2nd Annual Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA. Dr. Hanash will speak on “Biomarker Discovery: Lessons Learned.” |
|
09 APR |
Chris Austin To Give Keynote Presentation At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6 |
| Chris Austin, Director of the NIH Chemical Genomics Center to give Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA |
|
03 APR |
Hakim Djaballah, Director Of Hts At Memorial Sloan Kettering Cancer Center To Present At Gtcbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 In San Francisco, CA |
| Dr. Hakim Djaballah, Director of High Throughput Screening Core Facility at the Memorial Sloan Kettering Cancer Center will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Djaballah will speak on successful applications of high content assays using confocal microscopy. |
|
03 APR |
John Cuozzo, Director Of ELT Lead Discovery At Glaxosmithkline To Present At GTCbio's 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 In San Francisco, CA |
| Dr. John W. Cuozzo, Director of ELT Lead Discovery at GlaxoSmithKline will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Cuozzo will speak on selecting hits from billions of compounds from encoded library technology. |
|
03 APR |
Xi Chen To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6 |
| Xi Chen, Assistant Professor at University of California, Davis to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA |
|
03 APR |
Taosheng Chen To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6 |
| Taosheng Chen, Director of HTS, St. Jude Children's Research Hospital to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA |
|
03 APR |
Clay Scott Of Astrazeneca To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6 |
| Clay Scott, Associate Director of Lead Generation at AstraZeneca to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA |
|
29 MAR |
Dr. Susan Taylor, Professor Of Pharmacology At UCSD To Give Featured Presentation At Gtcbio’s 3rd Protein Kinase In Drug Discovery Conference On May 5-6 |
| Dr. Susan Taylor, Professor of Pharmacology at UCSD, will be giving the Featured Presentation at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA. |
|
29 MAR |
Dr. Karim Dabbagh, Director Of Pharmacology At Roche To Present At Gtcbio’s 3rd Protein Kinase In Drug Discovery Conference On May 5-6 |
| Dr. Karim Dabbagh the Director of Pharmacology at Hoffmann-La Roche will present at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA. |
|
27 MAR |
Samuel H. Wood, CEO At Stemagen Will Give A Featured Presentation At The 4th International Stem Cell Research & Therapeutics |
| Samuel H. Wood, CEO at Stemagen, which announced on January 17, 2008 that it has become the first in the world to create, and meticulously document, a cloned human embryo using somatic cell nuclear transfer (SCNT), will give a featured presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. |
|
27 MAR |
Pfizer To Present At GTCbio’s 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 In Boston, MA |
| Mark Thiede of Pfizer will give a presentation entitled “Inference by Interference: Controlling MSC Differentiation with RNAi” at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. |
|
27 MAR |
Jan Paul Medema, Professor Of Experimental Oncology And Radiobiology At The University Of Amsterdam To Present At Gtcbio’s 4th International Stem Cell Research & Therapeutics |
| Jan Paul Medema, Professor of Experimental Oncology and Radiobiology at the Academic Medical Center of the University of Amsterdam, will give a presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. |
|
27 MAR |
Senior Vice President Of Regenerative Medicine At Geron To Present At Gtcbio’s 4th International Stem Cell Research & Therapeutics, Apr 17- 18, 2008 In Boston, MA |
| Jane S. Lebkowski, Senior Vice President of Regenerative Medicine at Geron will give a presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. |
|
27 MAR |
President & Chief Executive Officer Of Sangamo Biosciences To Present At Gtcbio’s 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 In Boston, MA |
| Edward Lanphier, President & Chief Executive Officer at Sangamo BioSciences, which published a new study last October indicating that its technology could be used to modify the genomes in stem cells, create stem cell lines that mimic disease, and modify stem cells to treat diseases, will present at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. |
|
27 MAR |
Senior Director At Genzyme To Present At GTCbio’s 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 In Boston, MA |
| Bruce Wentworth, Senior Director of Cardiovascular Research at Genzyme will give a presentation entitled “Retention of Cells after Transplantation” at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. |
|
27 MAR |
Malcolm Moos, Medical Officer Of Division Of Cellular And Gene Therapies At FDA To Give Featured Presentation At The 4th International Stem Cell Research & Therapeutics |
| Malcolm Moos, Medical Officer of the Division of Cellular and Gene Therapies at the Food and Drug Administration (FDA) will give the featured presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. |
|
26 MAR |
GTCbio Announces Its 4th Modern Drug Discovery And Development Summit Taking Place On October 15-17, 2008 In San Diego, CA |
| GTCbio just announced its holding the annual Modern Drug Discovery and Development Summit taking place on October 15-17, 2008 in San Diego, CA. |
|
26 MAR |
Robert Hertzberg, Vice President Of Screening & Compound Profiling At GlaxoSmithKline To Give Keynote Presentation At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 200 |
| Dr. Robert Hertzberg, Vice President of Screening & Compound Profiling at GlaxoSmithKline will give the Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Hertzberg will present on “High Throughput Screening: A Technology That’s Easy to Love and Easy to Hate.” |
|
26 MAR |
Jeremy Caldwell To Give The Featured Presentation At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 In San Francisco, CA |
| Dr. Jeremy Caldwell, Executive Director of Molecular and Cell Biology at the Genomics Institute of the Novartis Research Foundation will give the Featured Presentation at GTCbio’s 4th Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Caldwell will discuss broad functional profiling of molecular libraries against biological space. |
|
26 MAR |
Berta Strulovici, Vice President Of Basic Research MRL, And Automated Biotechnology Head At Merck & Co. To Give Keynote At GTCbio’s 3rd Assay Development & Screening Technologies Conference |
| Dr. Berta Strulovici, Vice President of Basic Research MRL, and Automated Biotechnology Head at Merck & Co. will give Keynote Presentation at GTCbio’s 4th Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. |
|
08 MAR |
Massachusetts Senator Richard T. Moore To Give Keynote Presentation At GTCbio’s 4th International Conference On Stem Cell Research & Therapeutics On April 17-18, 2008 In Boston, MA |
| Senator Richard Moore will speak on April 18, 2008 on recent stem cell legislation and policy initiatives at GTCbio’s 4th International Conference on Stem Cell Research & Therapeutics in Boston, MA. |
|
08 JAN |
University Of Massachusetts To Present At GTCbio’s 6th Cytokines And Inflammation (January 28-29, 2008, Orlando, Florida) |
| Eicke Latz, Assistant Professor in Medicine of the Division of Infectious Diseases and Immunology at University of Massachusetts Medical School will give a presentation entitled “Mechanisms of Crystal Recognition by Inflammasomes” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida.) |
|
08 JAN |
Director, Molecular Imaging At GSK To Speak At 3rd Imaging In Drug Development Conference March 2008 |
| Susanta K. Sarkar, Director of the Molecular Imaging Center of Excellence at GlaxoSmithKline will speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego. |
|
08 JAN |
Joint Presentation From Novartis And Human Genome Sciences At Gtcbio’s 5th Anti-infectives Partnering & Deal-making Summit (march 5- 7, 2008, Philadelphia, Pa) |
| Mark Coflin, Global Executive Director of IDTI Alliance Mgmt at Novartis and Margery B. Fischbein, Vice President of Business Development & Strategic Planning at Human Genome Sciences will give a joint presentation at GTCbio’s 5th Anti-Infectives Partnering & Deal-Making Summit taking place on March 5-7 2008 in Philadelphia, PA. |
|
08 JAN |
Genentech To Present At Gtcbio’s 6th Cytokines And Inflammation (january 28-29, 2008, Orlando, Florida) |
| Dimitry M. Danilenko, Senior Pathologist of the Department of Pathology at Genentech will give a presentation entitled “IL-22, a Th17 Cytokine, Plays an Important Role in Psoriasis as well as in Mucocutaneous Host Defense” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida.) |
|
08 JAN |
Chief, Diagnostic Radiology At Nih To Speak At 3rd Imaging In Drug Development Conference March 2008 |
| MONROVIA, CA – Joseph Frank, Chief, Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology at NIH will speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego. |
|
08 JAN |
Biogen-Idec To Present At GTCbio’s 6th Cytokines And Inflammation (January 28-29, 2008, Orlando, Florida) |
| Shelia Violette, Director of Discovery Immunology at Biogen-Idec will give a presentation entitled “The Alphavbeta6 Integrin: A Mediator of TGF-Beta Activation and Therapeutic Target in Fibrosis and Oncology” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida. |
|
20 DEC |
Joost J. Oppenheim, Chief Of The Laboratory Of Molecular Immunoregulation At NCI, NIH To Present On Regulation Of T Regulatory Cells, January 28, 2008 |
| Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation at NCI, NIH, will be the honored keynote speaker at the 6th Cytokines and Inflammation conference to be held January 28-29, 2008 in Orlando, FL. |
|
20 DEC |
Big Pharmas To Present At GTCbio’s 3rd Imaging In Drug Development Conference In March 2008 |
| Presenters from GSK, Pfizer, Abbott, Schering-Plough, Bristol-Myers Squibb, GE, Siemens, NIH and more to speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego. |
|
10 NOV |
Kenna Anderes Of Pfizer, Michael Shi Of Novartis And Joseph Paul Eder Of Astrazeneca To Give Featured Presentations At Oncology Biomarkers: From Discovery To Validation Conference January 2008 |
| Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008. |
|
10 NOV |
Robert Copeland, Vp, Oncology Drug Discovery, Gsk To Give Keynote Talk At Cancer Drugs Conference |
| Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix |
|
18 OCT |
Dr. David Kaslow, Vice President Of Infectious Diseases And Vaccines At Merck To Give Keynote Presentation At 3rd Modern Drug Discovery & Development Summit |
| Dr. David Kaslow, VP of Infectious Diseases and Vaccines at Merck will give the Keynote presentation at GTCbio’s Biological Therapeutics conference – one of six tracks at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 at the Hyatt Regency San Francisco Airport. |
|
18 OCT |
Dr. Stephen K. Burley, CSO And SVP Of Research At SGX Pharmaceuticals Will Give The Keynote Presentation At 3rd Modern Drug Discovery & Development Summit |
| Dr. Stephen K. Burley, CSO and SVP of Research at SGX Pharmaceuticals will give the Keynote presentation at GTCbio’s Drug Design & Lead Discovery conference – one of six tracks at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 in San Francisco. |
|
15 OCT |
GTCbio’s 5th International Conference On Vaccines: All Things Considered |
| GTCbio announces it’s the 5th anniversary of its vaccine conference held annually in Washington D.C |
|
15 OCT |
Metabolic Disease Has A Greater Effect On The Health Of Our Society Than Cancer |
| The 3rd World Summit on Metabolic Diseases explores the latest findings and treatments for Metabolic Diseases |
|
10 OCT |
Gtcbio’s 3rd Modern Drug Discovery And Development Summit |
| GTCbio announces its flagship event – the 3rd Modern Drug Discovery and Development Summit (M3D) on Nov. 28-30, 2007 in San Francisco – featuring four plenary keynote speeches from top level execs at Pfizer, Eli Lilly, Wyeth as well as Nobel Laureate Ferid Murad at UT Houston. |
|
09 OCT |
SVP And Site Head Of Pfizer La Jolla To Give Plenary Keynote Address At 3rd Modern Drug Discovery & Development Summit |
| SVP and Site Head of Pfizer La Jolla announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D). |
| | Sitemap| Press Release Sitemap| Latest Companies| Buddies| Articles | PR Guidelines | Privacy Policy| Terms of Use| Contact Us |
|